-
1
-
-
0028156958
-
Lifetime and 12 month prevalence of DSM-3R psychiatric disorders in the united states
-
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, Wittchen H, Kendler KS: Lifetime and 12 month prevalence of DSM-3R psychiatric disorders in the united states. Archives of General Psychiatry 1994, 51:8-19.
-
(1994)
Archives of General Psychiatry
, vol.51
, pp. 8-19
-
-
Kessler, R.C.1
McGonagle, K.A.2
Zhao, S.3
Nelson, C.B.4
Hughes, M.5
Eshelman, S.6
Wittchen, H.7
Kendler, K.S.8
-
2
-
-
0028286733
-
Antidepressant efficacy and quality of life in Depression: A double blind study with moclobomide and Fluoxetine
-
Lonquist J, Sutonen H, Syvalahti E, Appleberg B, Koskinen T, Maninikko T, Mehtones OP, Narala M, Shiro S, Auvinen J: Antidepressant efficacy and quality of life in Depression: A double blind study with moclobomide and Fluoxetine. Acta Psychiatrica Scandinavia 1994, 89(6):363-9.
-
(1994)
Acta Psychiatrica Scandinavia
, vol.89
, Issue.6
, pp. 363-369
-
-
Lonquist, J.1
Sutonen, H.2
Syvalahti, E.3
Appleberg, B.4
Koskinen, T.5
Maninikko, T.6
Mehtones, O.P.7
Narala, M.8
Shiro, S.9
Auvinen, J.10
-
3
-
-
0027159399
-
Fluoxetine: A five-year review
-
Stokes PE: Fluoxetine: A five-year review. clinical therapeutics 1993, 15(2):216-43.
-
(1993)
Clinical Therapeutics
, vol.15
, Issue.2
, pp. 216-243
-
-
Stokes, P.E.1
-
4
-
-
0027754070
-
Paroxetine: An overview of the efficacy and safety of a new selective reuptake inhibitor in the treatment of depression
-
Nemeroff CB: Paroxetine: An overview of the efficacy and safety of a new selective reuptake inhibitor in the treatment of depression. Journal of clinical Psychopharmacology 1993, 13(suppl 2):10S-17S.
-
(1993)
Journal of Clinical Psychopharmacology
, vol.13
, Issue.2 SUPPL.
-
-
Nemeroff, C.B.1
-
5
-
-
0027439207
-
Neurological mechanisms involved in antidepressant therapies
-
Birley M, Moret C: Neurological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 1993, 16:387-400.
-
(1993)
Clin Neuropharmacol
, vol.16
, pp. 387-400
-
-
Birley, M.1
Moret, C.2
-
6
-
-
0027304897
-
The presence of serotonin (5-HT1) receptors negatively coupled to adenylate cyclase in rabbit and human iris-Ciliary processes
-
Barrett NL, Osbourne NN: The presence of serotonin (5-HT1) receptors negatively coupled to adenylate cyclase in rabbit and human iris-Ciliary processes. Exp Eye Res 1993, 57:209-16.
-
(1993)
Exp Eye Res
, vol.57
, pp. 209-216
-
-
Barrett, N.L.1
Osbourne, N.N.2
-
7
-
-
0023260484
-
Serotonin accumulating cells in the iris-Ciliary body and cornea of various species
-
Osbourne NN, Tobin AB: Serotonin accumulating cells in the iris-Ciliary body and cornea of various species. Exp Eye Res 1987, 44:731-46.
-
(1987)
Exp Eye Res
, vol.44
, pp. 731-746
-
-
Osbourne, N.N.1
Tobin, A.B.2
-
8
-
-
0027945582
-
Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular presence
-
Osbourne NN: Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular presence. Acta Neurobiol Exp 1994, 54(Suppl):57-64.
-
(1994)
Acta Neurobiol Exp
, vol.54
, Issue.SUPPL.
, pp. 57-64
-
-
Osbourne, N.N.1
-
9
-
-
85044046851
-
Fluoxetine oral administration increases intraocular pressure
-
Costagliola C, Mastropasqua L, Streado L: Fluoxetine oral administration increases intraocular pressure. Br J Opthalmol 1996, 80:678.
-
(1996)
Br J Opthalmol
, vol.80
, pp. 678
-
-
Costagliola, C.1
Mastropasqua, L.2
Streado, L.3
-
10
-
-
0027251271
-
Effect of topical of Ketanserin administration on intra-ocular pressure
-
Costagliola C, Inliano G, Rinaldi M: Effect of topical of Ketanserin administration on intra-ocular pressure. Br J Ophthalmol 1993, 77:344-8.
-
(1993)
Br J Ophthalmol
, vol.77
, pp. 344-348
-
-
Costagliola, C.1
Inliano, G.2
Rinaldi, M.3
-
11
-
-
0042355192
-
Drug - Induced glaucoma's: Mechanisms and management
-
Tripathi RC, Tripathi BJ, Haggerty C: Drug - induced glaucoma's: mechanisms and management. Drugs safety 2003, 26(11):749-767.
-
(2003)
Drugs Safety
, vol.26
, Issue.11
, pp. 749-767
-
-
Tripathi, R.C.1
Tripathi, B.J.2
Haggerty, C.3
-
12
-
-
0029980777
-
Number of people with glaucoma worldwide
-
Quigley HA: Number of people with glaucoma worldwide. Br J Opthalmol 1996, 80(5):389-393.
-
(1996)
Br J Opthalmol
, vol.80
, Issue.5
, pp. 389-393
-
-
Quigley, H.A.1
-
13
-
-
0029928269
-
The epidemiology and control of open angle glaucoma. A population based perspective
-
Tielsch JM: The epidemiology and control of open angle glaucoma. A population based perspective. Annu Rev Public Health 1996, 17:121-36.
-
(1996)
Annu Rev Public Health
, vol.17
, pp. 121-136
-
-
Tielsch, J.M.1
-
14
-
-
0032889609
-
Predisposing factors for chronic angle-closure glaucoma
-
Salmon JF: Predisposing factors for chronic angle-closure glaucoma. Prog Retin Eye Res 1999, 18(1):121-32.
-
(1999)
Prog Retin Eye Res
, vol.18
, Issue.1
, pp. 121-132
-
-
Salmon, J.F.1
-
15
-
-
0014011252
-
Amitriptyline and glaucoma
-
Lowe RF: Amitriptyline and glaucoma. Med J Aust 1966, 2:509-510.
-
(1966)
Med J Aust
, vol.2
, pp. 509-510
-
-
Lowe, R.F.1
-
16
-
-
0028144596
-
Oral imipramine and acute angle closure glaucoma
-
Ritch R, Krupin T, Henry C, Kurata F: Oral imipramine and acute angle closure glaucoma. Arch Ophthalmol 1994, 112:67-68.
-
(1994)
Arch Ophthalmol
, vol.112
, pp. 67-68
-
-
Ritch, R.1
Krupin, T.2
Henry, C.3
Kurata, F.4
-
17
-
-
0037017758
-
Venlafaxine and bilateral acute closure glaucoma
-
Bradley NG, Sanbrook MC, Malourf AJ, Agarwal SA: Venlafaxine and bilateral acute closure glaucoma. Med J Aust 2002, 4;176(5):241.
-
(2002)
Med J Aust
, vol.176
, Issue.5
, pp. 241
-
-
Bradley, N.G.1
Sanbrook, M.C.2
Malourf, A.J.3
Agarwal, S.A.4
-
18
-
-
0030899991
-
Acute angle closure glaucoma associated with Paroxetine
-
Eke T, Bates AK: Acute angle closure glaucoma associated with Paroxetine (letter). BMJ 1997, 314:1387.
-
(1997)
BMJ
, vol.314
, pp. 1387
-
-
Eke, T.1
Bates, A.K.2
-
19
-
-
0033799065
-
Bilateral angle closure glaucoma and visual loss precipitated by antidepressant and ant anxiety agents in a patient with depression
-
Kadoi C, Hayasaka S, Tsukamoto E, Matsumoto M, Hayasaka Y, Nagaki Y: Bilateral angle closure glaucoma and visual loss precipitated by antidepressant and ant anxiety agents in a patient with depression. Opthalmologica 2000, 214:360-361.
-
(2000)
Opthalmologica
, vol.214
, pp. 360-361
-
-
Kadoi, C.1
Hayasaka, S.2
Tsukamoto, E.3
Matsumoto, M.4
Hayasaka, Y.5
Nagaki, Y.6
-
20
-
-
0026148714
-
Fluoxetine and glaucoma
-
Ahmad S: Fluoxetine and glaucoma (letter). Drug intell clin Pharm 1991, 25(4):436.
-
(1991)
Drug Intell Clin Pharm
, vol.25
, Issue.4
, pp. 436
-
-
Ahmad, S.1
-
21
-
-
0031656060
-
Acute glaucoma, chronic glaucoma and serotonergic drugs
-
Eke T, Carr S: Acute glaucoma, chronic glaucoma and serotonergic drugs. Br J Ophthalmol 1998, 82:976-979.
-
(1998)
Br J Ophthalmol
, vol.82
, pp. 976-979
-
-
Eke, T.1
Carr, S.2
|